Basic Information
| LncRNA/CircRNA Name | GSTM3TV2 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | pancreatic cancer |
| ICD-0-3 | C25 |
| Methods | RNA-seq |
| Sample | pancreatic cancer tissues,cell line |
| Expression Pattern | differential expression |
| Function Description | Firstly, we demonstrated that lncRNAs were dysregulated in gemcitabine-resistant pancreatic cancer cells. |
| Pubmed ID | 31514732 |
| Year | 2019 |
| Title | Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer. |
External Links
| Links for GSTM3TV2 | GenBank HGNC NONCODE |
| Links for pancreatic cancer | OMIM COSMIC |